Orphazyme A/S ADR (ORPH) Social Stream



Orphazyme A/S ADR (ORPH): $4.40

-0.11 (-2.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ORPH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 505

in industry

Featured Post From StockTwits About ORPH

$CYTR Kriegsman is doing his best to make it appear as if he has no idea a buyout is coming.

Hire new personnel ✔️
Conduct an equity raise ✔️
Insert manipulative language into the share increase vote reminiscent of past missteps ✔️
Alter public commentary alluding now to the longer instead of shorter-term prospects ✔️

The only way my read is inaccurate is if $ORPH CEO Christophe Bourdon has conveyed negative sentiment relative to EU approval of arimoclomol. In that case - we’re all fucked.
ScryingBiotech, published August 14, 2021

What Else are ORPH Traders Talking About?


Other tickers frequently mentioned alongside ORPH is CYTR.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5038 seconds.